Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

You are here: Home / Statistics / Comparative statistics by cancer site (ICD-10)

You are here: Home / Statistics / Comparative statistics by cancer site (ICD-10)

Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site

Click on country-registry for comparison

Flag	Country Registry	Registration period	No. of cases included	Complete FU		Incomplete FU: loss to FU						% with Complete FU at 5 years	Median FU (in months)
				Alive/dead	At end of FU	No.	%	% lost to FU: years from diagnosis
				No.	%	No.	%	<1	1-3	3-5	>5
	China - Shangai	1992-1995	4782	4734	99.0	48	1.0	0.1	0.3	0.4	0.2	99.2	31.4
	Cuba	1994-1995	1248	1238	99.2	10	0.8	0.2	0.2	0.3	0.1	99.3	14.4
	India - Mumbai	1992-1994	1578	1315	83.3	263	16.7	9.2	0.2	0.1	7.2	90.6	8.4
	Philippines - Manila	1994-1995	145	119	82.1	26	17.9	13.1	2.1	2.7	0.0	82.1	15.7
	Thailand - Chiang Mai	1993-1997	237	174	73.4	63	26.6	9.4	8.4	4.6	4.2	77.6	14.6
	Thailand - Khon Kaen	1993-1997	242	193	79.8	49	20.2	6.6	6.2	5.4	2.0	81.8	18.2
	Thailand - Lampang	1990-2000	425	424	99.8	1	0.2	0.0	0.0	0.0	0.2	100.0	19.4
	Thailand - Songkhla	1990-1999	247	130	52.6	117	47.4	17.8	12.1	7.7	9.7	62.3	17.3
	Turkey - Izmir	1995-1997	371	266	71.7	105	28.3	11.1	3.0	1.3	12.9	84.6	28.2
	Uganda - Kampala	1993-1997	51	41	80.4	10	19.6	19.6	0.0	0.0	0.0	80.4	6.6
	Zimbabwe - Harare	1993-1997	57	57	100.0	0	0.0	0.0	0.0	0.0	0.0	100.0	14.6

Other tables available:

- Table 1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a:	Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b:	Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b:	Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6:	Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9:	Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period